Intelligyn

Building the future of women's health imaging diagnostics with AI-driven interpretation for gynecology.

Intelligyn is active in the health space based in Silicon Valley, California.

Profile

Intelligyn is a groundbreaking health tech company revolutionizing women's health diagnostics with AI-driven ultrasound interpretation. Their AI-powered clinical decision support tool aims to improve the accuracy of diagnosing gynaecological diseases, starting with ovarian tumors. By leveraging the largest curated dataset of ovarian tumors globally, Intelligyn's AI model surpasses individual human experts, ensuring consistent and reliable results across different settings and populations. Intelligyn's tool seamlessly integrates into clinical workflows, empowering clinicians of all experience levels to make faster, more confident decisions, ultimately reducing unnecessary surgeries and enhancing patient outcomes. Additionally, their upcoming AI-enhanced educational platform, SonoQz, will further support clinicians in ultrasound interpretation. With strong industry support and regulatory progress in the EU, Intelligyn is poised to expand its AI-driven diagnostic suite to address a range of women's health issues, including endometriosis, fertility, and early cancer detection.

Intelligyn is positioned in health, a segment that rewards a clear, focused offering.

The business is associated with Silicon Valley, California.

Directory data places it at the Plug and Play accelerated startup stage.

Website: www.intelligyn.ai/intelligynai